Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-κB activation in rat hepatocytes
- 1 June 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 30 (6) , 1138-1145
- https://doi.org/10.1016/s0168-8278(99)80270-0
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Human Inducible Nitric Oxide Synthase Gene Is Transcriptionally Regulated by Nuclear Factor-κB Dependent MechanismBiochemical and Biophysical Research Communications, 1996
- Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat modelImmunology, 1996
- Interleukin 1β-Induced Expression of Nitric Oxide Synthase in Rat Renal Mesangial Cells Is Suppressed by Cyclosporin ABiochemical and Biophysical Research Communications, 1995
- Cyclosporin A Inhibits Nitric Oxide Synthase Induction in Vascular Smooth Muscle CellsHypertension, 1995
- NITRIC OXIDE GENERATIONTransplantation, 1994
- Detection of the FK506-FKBP-Calcineurin Complex by a Simple Binding AssayBiochemical and Biophysical Research Communications, 1993
- Cloning of Inducible Nitric Oxide Synthase in Rat Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1993
- Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicityFEBS Letters, 1992
- FK 506 ameliorates the hepatic injury associated with ischemiaLife Sciences, 1989